ArticleThe Korean journal of internal medicine2026
Comparison of the efficacy and safety of endoscopic and fluoroscopic balloon dilatation in benign esophageal strictures.
Article in The Korean journal of internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimsBalloon dilatation under endoscopic or fluoroscopic guidance is regarded as the gold standard for treating benign esophageal strictures. However, no prior studies have compared endoscopic balloon dilatation (EBD) with fluoroscopic balloon dilatation (FBD). We aimed to compare the efficacy and safety of the two methods.
methodsSubjects who underwent balloon dilatation under endoscopic or fluoroscopic guidance for benign esophageal strictures between 2001 and 2018 were eligible. Their medical records were retrospectively reviewed, and clinical characteristics were investigated.
resultsFrom 201 patients, 60 patients underwent EBD, and the remaining 141 underwent FBD. The mean age was higher in the FBD group than in the EBD group (69.77 vs. 58.63 yr, p < 0.001). The most frequent etiology of the strictures was surgery in both groups. Longer procedure times, cervical esophageal location, and short stricture length were significantly associated with the FBD group. Multivariable analysis showed that old age (HR 1.028), higher dysphagia grade (HR 1.561 for grade II and HR 3.518 for grade III), and long stricture length (HR 1.943) were significantly associated with the short dilatation-free period. There were no significant differences in dilatation-free periods or adverse events between the groups.
conclusionBoth EBD and FBD are safe and effective primary treatment modalities for treating benign esophageal strictures. Choosing an appropriate method depending on the location and length of the stricture and the institution's capacity and resources would produce more effective results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.